JIM
SCLN

Jupiter Investment Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Jupiter Investment Management’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-132,215
Closed -$1.35M – 455
2016
Q3 		$1.35M Buy
+132,215
New +$1.44M 0.02% 227

Other funds holding SCLN

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Jupiter Investment Management's SCLN Position: Q4 2016 in Review

Jupiter Investment Management sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2016, closing a stake of 132,215 shares — an estimated $1.35M sold.

Jupiter Investment Management first reported a position in SCLN in Q3 2016 and held it in 1 quarter. The position peaked at $1.35M in Q3 2016. 153 funds tracked by Wall St. Rank hold SCLN as of Q4 2016.

  • Jupiter Investment Management reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2016 after selling out during the quarter.
  • Jupiter Investment Management sold 132,215 Sciclone Pharmaceuticals Inc shares in Q4 2016, an estimated $1.35M.
  • Jupiter Investment Management first reported a position in Sciclone Pharmaceuticals Inc in Q3 2016 and held it in 1 quarter.
  • Jupiter Investment Management's Sciclone Pharmaceuticals Inc position peaked at $1.35M in Q3 2016.
  • 153 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2016.

Based on Jupiter Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.